| [공지] |
2026년 학회 및 전시정보  |
관리자 |
2026.01.01 |
213 |
| 58 |
[Citation] A therapeutic human antibody against the domain 4 of the Bacillus anthracis |
관리자 |
2026.03.26 |
31 |
| 57 |
[논문] B cell depletion in autoimmune diseae (In vivo CAR-T or T cell enagers) |
관리자 |
2026.03.18 |
61 |
| 56 |
[Technical Support] Engineering and reformatting your antibody from mAb to bsAb |
관리자 |
2026.03.10 |
93 |
| 55 |
[Citation] Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis |
관리자 |
2026.03.02 |
86 |
| 54 |
[Citation] Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice |
관리자 |
2026.02.20 |
109 |
| 53 |
[논문] Antibodies to watch in 2026 |
관리자 |
2026.02.03 |
122 |
| 52 |
[Technical Support] The real-time kinetic and affinity data for bsAb or Fc engineering |
관리자 |
2026.01.23 |
166 |
| 51 |
[논문] Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, |
관리자 |
2025.12.15 |
334 |
| 50 |
[Citation] Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis |
관리자 |
2025.11.26 |
328 |
| 49 |
[논문] Developability considerations for bispecific and multispecific antibodies |
관리자 |
2025.11.18 |
232 |
| 48 |
[Citation] Endogenous DEL-1 restrains melanoma lung metastasis by limiting |
관리자 |
2025.11.11 |
283 |
| 47 |
[논문] Bispecific antibodies: advancing precision oncology |
관리자 |
2025.11.03 |
305 |
| 46 |
[Citation] Colony-stimulating factor 3 |
관리자 |
2025.10.17 |
362 |
| 45 |
[논문] Quantifying antibody binding techniques and therapeutic implications |
관리자 |
2025.08.18 |
646 |
| 44 |
[논문] T cell- specific non- viral DNA delivery and in vivo CAR- T generation using targeted lipid nanoparticles |
관리자 |
2025.08.18 |
574 |
| 43 |
Discovery Antibody Screening Services |
관리자 |
2025.07.23 |
474 |
| 42 |
[논문] Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery |
관리자 |
2025.06.30 |
461 |
| 41 |
[논문] Leveraging neonatal Fc receptor (FcRn) to enhanceantibodytransportacrosstheblood brain barrier |
관리자 |
2025.06.30 |
442 |
| 40 |
Ymax®-NANO : A Single Domain Antibody Library |
관리자 |
2025.06.30 |
747 |
| 39 |
[논문] TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer |
관리자 |
2025.06.01 |
439 |
